73 studies found for:    "Bronchiolitis obliterans"
Show Display Options
Rank Status Study
21 Completed
Has Results
Bronchodilator Responsiveness in Obliterative Bronchiolitis
Condition: Obliterative Bronchiolitis
Intervention: Drug: albuterol plus tiotropium
22 Recruiting Lung Function, LCI, Bronchial Inflammation and Epigenetics of Patients With BO
Condition: Bronchiolitis Obliterans
Intervention: Other: observation
23 Completed Forced Oscillation Versus Spirometry in Diagnosing Post Pulmonary Transplant Bronchiolitis Obliterans Syndrome
Condition: Bronchiolitis Obliterans Syndrome
Intervention: Other: Forced oscillation
24 Active, not recruiting A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD
Condition: Bronchiolitis Obliterans
Intervention: Drug: Bortezomib
25 Recruiting Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans
Conditions: Bronchiolitis Obliterans;   Constructive Bronchiolitis;   Graft Versus Host Disease
Intervention: Drug: Inhaled Cyclosporine Solution
26 Recruiting Sleep Disorders in Bronchiolitis Obliterans Syndrome 2&3
Conditions: Bronchiolitis Obliterans;   Sleep Disordered Breathing Central
Intervention: Procedure: Assessment of sleep disorders and treatment if required
27 Completed
Has Results
Respiratory Impedance and Obliterative Bronchiolitis
Conditions: Hematopoietic Stem Cell Transplantation;   Obliterative Bronchiolitis
Intervention: Drug: albuterol
28 Completed Tacrolimus Versus Cyclosporine for Immunosuppression After Lung Transplantation
Conditions: Bronchiolitis Obliterans;   Immunosuppression
Interventions: Drug: Tacrolimus;   Drug: Cyclosporine
29 Completed Use of Erythromycin in Mustard-Induced Bronchiolitis
Conditions: Bronchiolitis Obliterans;   Acute Obliterating Bronchiolitis
Intervention: Drug: Erythromycin
30 Recruiting AZD9668, an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Chronic Graft vs Host Disease;   Chronic Graft-Versus-Host-Disease;   Bronchiolitis Obliterans Syndrome
Intervention: Drug: AZD9668
31 Active, not recruiting
Has Results
Montelukast to Treat Bronchiolitis Obliterans
Conditions: Bronchiolitis Obliterans;   Chronic Graft Versus Host Disease;   Leukotriene;   Montelukast;   Stem Cell Transplant
Intervention: Drug: Singular (Montelukast Sodium)
32 Recruiting European Trial of Pirfenidone in BOS, A European Multi-center Study
Conditions: Disorder Related to Lung Transplantation;   CLAD, Bronchiolitis Obliterans
Interventions: Drug: Pirfenidone;   Drug: Placebo
33 Enrolling by invitation Immune Mechanisms of Rejection in Human Lung Allografts
Condition: Bronchiolitis Obliterans
Intervention:
34 Completed Bronchial Inflammation in Patients With Bronchiolithis Obliterans
Condition: Bronchiolitis Obliterans
Intervention:
35 Enrolling by invitation Imaging and Understanding BOS in Lung Transplantation
Condition: Bronchiolitis Obliterans Syndrome
Interventions: Drug: Hyperpolarized Helium-3 MRI;   Device: MRI
36 Completed Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation
Condition: Lung Transplant
Intervention: Drug: Cyclosporine Inhalation Solution (CIS)
37 Active, not recruiting Efficacy of Azithromycin to Prevent Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
Condition: Malignant Hematological Diseases
Interventions: Drug: Azithromycin;   Drug: Placebo
38 Active, not recruiting Mesenchymal Stem Cell Therapy for Lung Rejection
Conditions: Lung Transplant Reject;   Bronchiolitis Obliterans
Intervention: Biological: Mesenchymal stem cell
39 Completed
Has Results
Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS)
Condition: Complication of Transplanted Lung
Interventions: Drug: Aztreonam Lysine for Inhalation (AZLI);   Procedure: Status Post Lung Transplant
40 Completed Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients
Conditions: Disorder Related to Lung Transplantation;   Bronchiolitis Obliterans;   Decreased Immunologic Activity;   Chronic Rejection of Lung Transplant
Interventions: Drug: liposomal aerosol cyclosporine;   Other: standard immune suppression, oral

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.